Omada Health
NASDAQ:OMDAMedical - Healthcare Information Services
+$0.13 today
- Market cap
- $817.04M
- Beta
- 2.09
- P/E (TTM)
- -162.6
- EPS (TTM)
- -$0.11
Volume 1.68M
Average 1.07M
OMDA Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Omada HealthNASDAQ: OMDA
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI remains negative
Q1 FY2026 Accumulated OCI was $0, compared with $0 a year earlier.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Accumulated OCI increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Accumulated OCI vs competitors
How OMDA compares with its peers on the latest reported figures
- OMDA's Mar 2026 Accumulated OCI of $0 is the highest of the 5 companies compared; the peer median is -$21.42M.
- Accumulated OCI amounts to 0.0% of total assets for OMDA, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | -$364K | -970.6% | — | 0.0% | |
| Mar 2026 | -$12.07M | +25.4% | — | 3.7% | |
| Sep 2026 | -$30.76M | -3439.7% | — | 0.9% | |
| Mar 2026 | -$35.42M | +4.9% | — | 1.3% | |
| Peer median (excluding OMDA) | -$21.42M | -482.8% | — | 1.1% | |
Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 168.12M | 115.64M | 76.39M | 222.04M |
| Short-term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 11.67M | 16.44M | 23.92M | 34.59M |
| Inventory | 3.54M | 3.61M | 3.3M | 4.49M |
| Other Current Assets | 2.26M | 3.91M | 5.16M | 11.83M |
| Total Current Assets | 188.56M | 142.88M | 113.06M | 272.93M |
| Property, Plant & Equipment (Net) | 6.06M | 5.6M | 6.07M | 7.94M |
| Goodwill | 13.24M | 13.24M | 13.24M | 13.24M |
| Intangible Assets | 8.31M | 6.27M | 4.26M | 2.41M |
| Long-term Investments | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 5.63M | 7.09M | 14.26M | 8.88M |
| Total Non-current Assets | 33.24M | 32.2M | 37.83M | 32.47M |
| Total Assets | 221.8M | 175.08M | 150.89M | 305.41M |
| Account Payables | 4.11M | 3.62M | 4.17M | 10.28M |
| Short-term Debt | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 13.44M | 14.89M | 19.53M | 25.06M |
| Other Current Liabilities | 9.99M | 15.49M | 21.12M | 40.39M |
| Total Current Liabilities | 34.51M | 43.79M | 53.95M | 75.73M |
| Long-term Debt | 28.9M | 29.38M | 29.77M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.52M | 2.58M | 2.54M | 0 |
| Total Non-current Liabilities | 31.68M | 32.37M | 32.31M | 0 |
| Total Liabilities | 66.19M | 76.16M | 86.26M | 75.73M |
| Common Stock | 21K | 7K | 8K | 58K |
| Retained Earnings | (329.32M) | (396.83M) | (443.97M) | (456.74M) |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Total Equity | 155.61M | 98.92M | 64.63M | 229.68M |
| Total Debt | 30.81M | 30.58M | 30.19M | 0 |
| Net Debt | (137.31M) | (85.06M) | (46.21M) | (222.04M) |
Omada Health
NASDAQ:OMDA
Intrinsic Alpha fair value
Locked
Current Price
$13.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.